Pharmaceutical Technology
CSL Honoured As Overall Winner Of The 2025 Facility Of The Year Awards By The International Society For Pharmaceutical Engineering (ISPE)
Share
Setting new standards in responsible innovation, CSL's Broadmeadows facility blends Pharma 4.0™ principles with sustainable design to transform plasma manufacturing
BROADMEADOWS, AUSTRALIA, Oct. 26, 2025 /PRNewswire/ -- CSL's base fractionation facility in Broadmeadows, Australia has been recognised as the Overall Winner of the 2025 Facility of the Year Award (FOYA) by the International Society for Pharmaceutical Engineering (ISPE).
Purpose-built to optimise the production of plasma-derived therapies for conditions such as immunodeficiencies, neurological disorders, and burns, the Broadmeadows facility combines cutting-edge technologies with a pioneering hybrid manufacturing platform. Key features include advanced automation, real-time production monitoring, robotics, and digital twin infrastructure that enable flexible multi-process manufacturing, fully paperless execution and continuous improvement. Its modular design ensures scalability and long-term adaptability.
These advancements have increased plasma processing capacity nine-fold – enabling the facility to handle over 10 million litres annually – while boosting efficiency and yield, which enables CSL to impact the lives of more patients globally.
"This prestigious award underscores CSL's unwavering commitment to innovation, operational excellence, and sustainability, and positions the Broadmeadows facility as a global benchmark in next-generation biopharmaceutical manufacturing. The Facility of the Year Award is a tribute to the dedication and collaboration of our entire team – across functions and continents," emphasised Andrew Hodder, VP Manufacturing and Site Head at Broadmeadows.
The facility's sustainable infrastructure plays a vital role in advancing CSL's commitment to responsible innovation and long-term impact, with innovations such as reusable filters, energy-efficient systems, and a fully automated warehouse powered by robotic vehicles for seamless material handling. "By combining automation, digital innovation, and sustainable design, we've built a future-ready facility that not only meets the highest standards in pharmaceutical manufacturing but also sets a new benchmark for responsible innovation", underlined Jeffrey Ball, Chief Sustainability Officer and Senior Vice President for EHS, Strategy & Engineering.
This recognition builds on the facility's earlier achievement in May 2025, when it received the ISPE FOYA award in the Pharma 4.0™ category for its advanced use of digital technologies and automation to transform pharmaceutical manufacturing.
About CSL
CSL (ASX: CSL; USOTC: CSLLY) is a leading global biopharma company with a dynamic portfolio of lifesaving medicines, including those that treat haemophilia and immune deficiencies, vaccines to prevent influenza, and therapies in iron deficiency, dialysis and nephrology. Since our start in 1916, we have been driven by our promise to save lives using the latest technologies. Today, CSL – including our three businesses, CSL Behring, CSL Seqirus and CSL Vifor – provides lifesaving products to patients in more than 100 countries and employs 29,000+ people. Our unique combination of commercial strength, R&D focus and operational excellence enables us to identify, develop and deliver innovations so our patients can live life to the fullest. For inspiring stories about the promise of biotechnology, visit CSL.com/Vita
For more information about CSL, visit CSL.com.
Media Contact
In Australia
Jeff Spicer
Mobile: +6 1410974799
Email: Jeff.Spicer@csl.com.au
In Europe
Pia Amend
Mobile: +49 151 25235305
Email: Pia.Amend@cslbehring.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/csl-honoured-as-overall-winner-of-the-2025-facility-of-the-year-awards-by-the-international-society-for-pharmaceutical-engineering-ispe-302594831.html
SOURCE CSL
Frequently Asked Questions
What is the Facility of the Year Award?
The Facility of the Year Award (FOYA) is given by the International Society for Pharmaceutical Engineering (ISPE) to recognize innovative pharmaceutical manufacturing facilities.
What makes the CSL Broadmeadows facility special?
The facility combines Pharma 4.0 principles with sustainable design and advanced automation to optimize plasma-derived therapies production.
What are some of the key features of the CSL Broadmeadows facility?
Key features include advanced automation, real-time production monitoring, robotics, digital twin infrastructure, reusable filters and energy-efficient systems.
First published on Mon, Oct 27, 2025
Enjoyed what you've read so far? Great news - there's more to explore!
Stay up to date with the latest news, a vast collection of tech articles including introductory guides, product reviews, trends and more, thought-provoking interviews, hottest AI blogs and entertaining tech memes.
Plus, get access to branded insights such as informative white papers, intriguing case studies, in-depth reports, enlightening videos and exciting events and webinars from industry-leading global brands.
Dive into TechDogs' treasure trove today and Know Your World of technology!
Disclaimer - Reference to any specific product, software or entity does not constitute an endorsement or recommendation by TechDogs nor should any data or content published be relied upon. The views expressed by TechDogs' members and guests are their own and their appearance on our site does not imply an endorsement of them or any entity they represent. Views and opinions expressed by TechDogs' Authors are those of the Authors and do not necessarily reflect the view of TechDogs or any of its officials. While we aim to provide valuable and helpful information, some content on TechDogs' site may not have been thoroughly reviewed for every detail or aspect. We encourage users to verify any information independently where necessary.
Trending PR Newswire
Atlas Data Storage Introduces The World's First Scalable DNA Data Storage Offering
Connectbase Acquires Cloud Age, Expanding Its Role As The Operating System For Transacting In The Connected World
Cresta Automation Discovery Provides A Blueprint For Where And How To Deploy AI Agents
Medtronic Begins U.S. Commercial Launch Of The Minimed 780G System With The Instinct Sensor, Made By Abbott
Premium Guard Inc. Welcomes Darren Phillips As SVP Of Sales & Business Development
Join Our Newsletter
Get weekly news, engaging articles, and career tips-all free!
By subscribing to our newsletter, you're cool with our terms and conditions and agree to our Privacy Policy.
Join The Discussion